DEVICE: Liofilchem Mic Test Strip (MTS) (08055182871704)
Device Identifier (DI) Information
Liofilchem Mic Test Strip (MTS)
Ciprofloxacin CIP 0.002-32 μg/mL 10 Strips
In Commercial Distribution
$92045-10
LIOFILCHEM SRL
Ciprofloxacin CIP 0.002-32 μg/mL 10 Strips
In Commercial Distribution
$92045-10
LIOFILCHEM SRL
The MTS™ (MIC Test Strip) Ciprofloxacin 0.002-32 μg/mL is a quantitative method intended for the in vitro determination of antimicrobial susceptibility of bacteria. MTS™ consists of specialized paper impregnated with a pre-defined concentration gradient of an antimicrobial agent, which is used to determine the minimum inhibitory concentration (MIC) in μg/mL of antimicrobial agents against bacteria as tested on agar media using overnight incubation and manual reading procedures.
The MTS™ Ciprofloxacin at concentrations of 0.002-32 μg/mL should be interpreted at 16-20 hours of incubation.
MTS™ Ciprofloxacin can be used to determine the MIC of ciprofloxacin against the following bacteria.
Ciprofloxacin has been shown to be active both clinically and in vitro against these bacterial species according to the FDA drug approved label:
Gram-negative bacteria
Citrobacter freundii
Citrobacter koseri
Enterobacter cloacae
Escherichia coli
Klebsiella pneumoniae
Morganella morganii
Proteus mirabilis
Proteus vulgaris
Providencia rettgeri
Providencia stuartii
Pseudomonas aeruginosa
Serratia marcescens
Device Characteristics
| Labeling does not contain MRI Safety Information | |
| No | |
| No | |
| Yes | |
| No | |
| No | |
| No | |
| No | |
| No |
GMDN
[?]GMDN© Term Code, Names and Definitions (*Terms of Use): GMDN® is a registered trademark of The GMDN Agency. All rights reserved. Used under licence from The GMDN Agency Ltd.
| GMDN Term Code | GMDN Term Name | GMDN Term Definition | GMDN Term Status [?] | Implantable? |
|---|---|---|---|---|
| 37300 | Multiple antibacterial minimum inhibitory concentration (MIC) IVD, kit |
A collection of reagents or test strips, and other associated materials, containing multiple antibacterial/antibiotic agents (i.e., a drug intended for treatment and/or prevention of a bacterial infection, excluding mycobacterial infection) at specified concentration gradients, intended to be used to determine the degree of susceptibility or the minimum inhibitory concentration (MIC) of a range of antibacterials against a specific bacterial microorganism, isolated from a clinical specimen by culture.
|
Active | false |
FDA Product Code
[?]| Product Code | Product Code Name |
|---|---|
| JWY | Manual Antimicrobial Susceptibility Test Systems |
FDA Premarket Submission
| FDA Premarket Submission Number [?] | Supplement Number [?] |
|---|---|
| K183527 | 000 |
Sterilization
Storage and Handling
[?]| Storage and Handling |
|---|
| Storage Environment Temperature: between -20 and 8 Degrees Celsius |
Clinically Relevant Size
[?]| Size Type Text |
|---|
| No Device Sizes |
Device Record Status
866b559c-02f1-4909-a394-8486f2a7ac68
April 29, 2019
1
April 19, 2019
April 29, 2019
1
April 19, 2019
Alternative and Additional Identifiers Additional Identifiers
Package DI
[?]| Package DI Number | Quantity per Package | Contains DI Package | Package Discontinue Date | Package Status | Package Type |
|---|---|---|---|---|---|
| 18055182871701 | 10 | 08055182871704 | In Commercial Distribution | box |
Secondary DI
[?]| Issuing Agency [?] | Secondary DI Number |
|---|---|
| No Secondary DIs found | |
Unit of Use DI
[?]
Unit of Use DI Number:
08055182871681
CLOSE
Direct Marking (DM)
[?]Production Identifier(s) in UDI
[?]Customer Contact
[?]
No Customer Contact currently defined